{
    "2019-01-10": [
        [
            {
                "time": "2018-01-02",
                "original_text": "High-Cap Stocks Paying High Dividend Yields",
                "features": {
                    "keywords": [
                        "High-Cap",
                        "Stocks",
                        "Paying",
                        "High",
                        "Dividend",
                        "Yields"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "3 Big Reasons Why AbbVie Isn't Worried About Humira",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Humira",
                        "Big",
                        "Reasons",
                        "Worried"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "3 Dividend Stocks That Pay You Better Than Coca-Cola Does",
                "features": {
                    "keywords": [
                        "Dividend",
                        "Stocks",
                        "Pay",
                        "Coca-Cola"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Ex-Dividend Reminder: Publix Super Markets, AbbVie and Quest Diagnostics",
                "features": {
                    "keywords": [
                        "Ex-Dividend",
                        "Publix",
                        "Super",
                        "Markets",
                        "AbbVie",
                        "Quest",
                        "Diagnostics"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "retail",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Top Ranked Momentum Stocks to Buy for January 10th",
                "features": {
                    "keywords": [
                        "Top",
                        "Ranked",
                        "Momentum",
                        "Stocks",
                        "Buy",
                        "January",
                        "10th"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "3 Big Reasons Why AbbVie Isn't Worried About Humira",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Humira",
                        "Big",
                        "Reasons",
                        "Worried"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}